-- Intro music of The Green Room begins, followed by an introduction from the host. --
Hannah Gowen (Host)
There's more to progress than just working hard. Sometimes it's necessary to step back, rethink and ask a different question altogether. But for organisations, changing course isn't always as simple as stopping one thing and starting another. Just because a better approach exists, it's not always possible to prioritise it. Today we ask: How do we rethink the way we solve problems?
-- The podcast transitions into showcasing highlight clips from the upcoming episode. --
Sir Jim Mackey (Guest)
I wouldn’t buy the NHS is fossilised, is unable to change, is resistant to change.
Sara Siegel (Guest)
When I speak to colleagues who work in other industries, financial services or consumer products, they always look at health services and think “why doesn’t it work like the banking app on my phone?”
Sir Jim Mackey (Guest)
We need to find a new imperative, this all is a bit urgent, it’s a bit existential, what are we gonna do about it.
Sara Siegel (Guest)
We are kind of in a way, in a race with AI, but in a good, competitive race.
Sir Jim Mackey (Guest)
The NHS is reinventing itself every day in every single institution.
Sara Siegel (Guest)
I really think we are on the cusp of the most exciting two to five years in healthcare because we do have all of these new tools at our disposal.
-- The podcast music ends and it transitions into the main episode, starting with our hosts introduction --
Hannah Gowen (Host)
Hello and welcome to The Green Room by Deloitte. Today we are out of the studio again. We're at the Freeman Hospital in Newcastle. You'll realise why in just a second. I'm Hannah Gowen and I'm joined today by my co-host Gerry Popova.
Gerry Popova (Host)
Thanks Hannah, it's a real pleasure to be here. And today we're joined by Sir Jim Mackey, NHS England CEO. Thank you for joining us, Jim. And thank you for hosting us today. We're also joined by a returning face to the podcast, Sara Siegel, who is Deloitte Global Sector leader for healthcare. Welcome back Sara.
Sara Siegel (Guest)
Thank you.
Gerry Popova (Host)
Let's look at the organisations first. Sometimes we know that organisations can get stuck on a recurring challenge. And they might recognise that a different approach already exists, but they might find it very difficult to move towards it. I'll open this question to both of you. But Jim, let's start with you. Why do you think a challenge can get stuck in a recurring cycle, even when a new approach might already be available?
Sir Jim Mackey (Guest)
This is a really big challenge for the health service at the minute, not just here, I think worldwide, because we're all in a world where we have to deliver better results today and tomorrow, but the same people who are delivering that have to find a new way of doing things. So there's a sort of there's a limit on human capacity and capability, time, headroom, but also the psychology of embracing something that's really different and disruptive. And the risk that that brings and the concern that that brings that sometimes defeats embracing it properly and finding a way to do it.
But our main problem I think currently in our system is just that balance between day-to-day, the requirements to get results and have an impact for patients, etc. And just being able to spend the time, understand what might work somewhere else that might release you from that.
Gerry Popova (Host)
Absolutely. And, Sara, from your professional perspective, what do you think?
Sara Siegel (Guest)
I totally agree with Jim, unsurprisingly, and part of my role is that I get to work with health systems outside the NHS in other countries, and it's, as Jim said, exactly the same challenges. We tend to categorise them into three buckets: unrelenting rises in cost to deal with, challenges with workforce, which is tied into the cost. We're just never going to have enough healthcare workers for the scale of the demand. And access, just not enough access points and equality of access. And those are not separate issues. They're all tied together. But those three things are what is sort of the anchor around the neck of health systems around the world.
And it is so hard to get away from just the day-to-day firefighting, trying to keep on top of things, to think about how you systemically solve those problems. And there's no extra money to do so. I'd say, and I'd love your views on this, Jim, like one sort of light in the tunnel that we've seen recently, because obviously there's lots of new technology. And if you read the news, it's all so exciting. But it's hard to get all of that exciting, you know, technology into the hands of clinicians and managers to transform health services. One thing that has disseminated quickly and that clinicians love is, is AVT is this ambient voice technology.
And that is the first thing where I've seen clinicians say, “actually, I love this, you know, can I have more, please?” Because it's giving them time back in the evenings when they were writing up notes. It's allowed them to look their patients in the eye during a consultation instead of being over here typing what the patients are saying. And they finally had a light bulb go off in their head and they're like, oh, I see how technology can actually, A, make me enjoy my job more and make it more efficient.
Gerry Popova (Host)
Picking up on something that you mentioned, Jim, that those requirements day-to-day, can the pressures of those immediate demands make it more difficult to focus on that long-term change?
Sir Jim Mackey (Guest)
It can do. And honestly, I think in my interactions with leaders in the health service, this is one of, if not the thing we talk about more than anything else. And it's often presented as binary. “I can do the future or I can do today, you tell me which one you want me to do” kind of thing. Good news and bad news is we can't do that. We have to find ways of doing both. So that's hard. But it's also where a lot of the joy and the complexity of doing these sorts of jobs is, how you navigate those challenges, how you find ways of bringing the future to life, how you.. I’ve got a national colleague who talks about the future being the thing that comes to rescue you today, the future solutions makes today easier, rather than it feeling like one has to happen with the other. So I think there's a sort of real-life recognition of it, that it's part of what makes these jobs interesting and most people who do these sorts of jobs and the NHS are doing them because there's value and there's complexity, and it's genuinely really challenging, but it can feel a bit overwhelming at times, and how you get the balance right.
And also in the leadership jobs, it's not... there's this sort of you component, but there's the leading others bit and how you get others to embrace it as well. And you can, you know, you've got a job to do to help, even if you can get your head around how you do the future and today, at the same time, persuade others that they can and find ways of convincing them that they can be good. That's where the joy is.
Sara Siegel (Guest)
One of the things that Jim presided over was ‘The 10 Year Plan’, which had three big shifts in it, and one of the shifts was from sickness to prevention. And that's a big kind of today versus tomorrow challenge. And we had the pleasure of working on that part of the report, or a precursor to that part of the report, along with Google and the Royal Society, with Lord Darzi to feed in, as many, many others did, to the thinking that went into ‘The 10 Year Plan’.
And one of the things that we found when we did that work was we did some economic analysis, and we found, unsurprisingly, that if you spend a pound on prevention when a child is a baby, it comes back to you, you know, between 30 and 300 x, you know, by the time you know, they are an older person and it accrues to all parts of society, not just to the health service, but it goes into the tax take because they’re a more productive worker, etc., etc. But how you actually find the time and space to spend that money effectively to prevent the diseases of the future is really hard.
And we debated some pretty radical things like, I mean, maybe shut your ears for this one, Jim. But like, should prevention even be the role of the NHS? The NHS has its hands full with caring for people who are unwell today. Like is that something which needs to be stood up separately? There's lots of countries that are starting to play with this and trying to figure out how to think about the future while still dealing with the today.
Hannah Gowen (Host)
And Sara, you're clearly, when you're working with clients very focussed on those long-term opportunities, what do you think the consequences are of ignoring those when you are dealing with the day-to-day firefighting?
Sara Siegel (Guest)
Well, I think we're seeing it now, right? Like the rubber is really hitting the road with the service. We, and Jim can be more articulate about this than I can, but we had the service that was built in the 1940s for acute illness, for broken bones and heart attacks, and now we're living in an age where we have all these chronic illnesses, and we're not structured to effectively deal with those based on the configuration of the service, both with physical architecture and with digital architecture. And the service just isn't coping. And add to that the challenges that Jim and I already mentioned about just incredibly rising costs.
Now, I think we're lucky because science and innovation are bringing us disruptive technologies like GLP-1s, which over the next couple of years I think will take a chunk out of the pain of diseases like diabetes, which are putting a huge burden on the population and the service. Do you agree?
Sir Jim Mackey (Guest)
Completely agree. How people are really concerned about the NEAT thing, and childhood obesity, and the mental health crisis. You know, all those sorts of things. But then the general discussion was we could go back a few steps. And for various reasons, children move less, they exercise less... they’re unable to, the curricula, the facilities, the things that I benefited from when I was a kid coming through, you’d do PE every day we’d play football every lunchtime. We'd do something after school. All those things were different then, and it's all relatively cheap stuff to do, it's actually.
But it requires agencies to work together, the public services to work together to make it accessible, remove the barriers about needing expensive kit, you know, etc. I am quite bothered that we would treat the end point. So the GLP-1 thing for example, is a great thing if you if you are carrying an awful lot of risk and it's been really effective for that, but we absolutely need to be going further upstream and trying to prevent the number of people coming through who need GLP-1s. So there’ll be a general theme, probably as we're talking about these. We've got lots of things that aren't mutually exclusive. They have to live with each other.
It's about how we get the balance right. And I think in the last ten years or so, we've just got a bit out of balance, probably exacerbated by Covid.
Gerry Popova (Host)
And leaders might think that there's more resource, for example, time or money that could be put into a problem to find that solution. But Jim, I'm very interested to know, how can a business tell when it's time to actually step back and consider whether the problem needs a completely different approach?
Sir Jim Mackey (Guest)
Again, I think you live with that all the time. I think especially where we are, where we've got so many things we need to tackle and challenge and change for the future, and there's a really palpable feeling in the service now. And I think in society here that we don't have a lot of time to do it. The economy is too fragile, society’s too fragile, public expectation, etc. so we are finding more and more we have to lean into that and disrupt as much as we can and find different ways of looking at a problem. Try and look at it through the lens of the consumer, the patient, the population.
Otherwise the risk is we build out of our current situation all the time. So we find tech solutions that are a front end to a current situation rather than a completely new situation. So I think the imperative's there and everyone's feeling the imperative and the urgency, it is hard to do. There's no one saying it's an easy thing to do. But I mentioned... I wouldn't want to talk about Covid a lot today, but in the space of a couple of weeks when we were all waiting for that to happen, there were techniques being developed, tried in real life and then adopted across the country. And we were watching clinical models change overnight.
And then we've, you know, we've found a lot of agility really quickly because there's a horrible fear element to it all. But we change things and it worked, broadly. I think we need to find a new imperative. That says, “actually this all is a bit urgent, it's a bit existential, what can I do about it?” Because we can't just allow the normal pattern of change to take place. we talk about in broader business.
Sara Siegel (Guest)
We talk about in broader business, you know, how can a legacy business which is doing fine disrupt itself? Would it cannibalise its core business? NHS Online is such a great example of this, and for our viewers who aren't NHS insiders, this is the concept of an NHS trust, which is entirely online. So it would be a different pathway, some direct access potentially to diagnostics or treatment options. All of that's being worked through now. But that is the kernel of, I think, how we would disrupt the NHS.
Hannah Gowen (Host)
I think the point on agility is, is really important, probably to this conversation and in the context of the NHS, more so. And the Covid example is really interesting because it demonstrated that that was possible. But in an organisation that is so vast and again, you're talking from an NHS England point of view, but the NHS is far greater than that. Is it a bigger problem that that agility is ramped up in those moments of perhaps crisis, but isn't necessarily happening day-to-day?
Sir Jim Mackey (Guest)
Again I think it's mixed. I think we can look at the NHS and look at it and think, why can't this thing move? And I've done this... the memory that comes to mind is sort of ten, eleven years ago when I was in a different job. I was sent to a place that was in a lot of trouble, and we were going to have to make changes to the board, and the place was going to go through a turnaround process and all the all the connotations was, and it's a big, esteemed teaching hospital, you know, built 500 years ago, etc.. So all the psychology was, this thing can't move stuck in the past.
It's all about history and old power. But in the building, I was reminded in the building there were things that were the best in the world. Conditions had been invented there and were only treated there in the whole of the country, and there were only a handful of places in the world that were doing it. So I think there's a danger that we'll look at the health service or even single institutions and think they are, they are one thing. They're actually multiple things, multiple cultures. They’ll be innovating in a way that people can't imagine.
But there will also be bits next door to it that do look like they were built for 400 or 500 years ago. We talk a lot about the outpatient model. I'm a bit obsessed about the outpatient model. It's a process that was developed hundreds of years ago, and it actually hasn't changed much in that time. So we have to find ways of breaking into all of this. But we are. And in the building we're in now, there are things going on upstairs in another, in a part of the building here where there's only two or three places in the country providing treatments that were just invented a few months ago.
I met a person upstairs here, who had been on a trial for 20 years and was given three months to live when they went on the trial. I wouldn't buy the NHS is fossilised, is unable to change, is resistant to change. I just think it's really complicated and it's actually multiple stories going on at the same time.
Sara Siegel (Guest)
And there's a piece in your question, Hannah, which I think is really important, which is the scale of the NHS. Like what you preside over, Jim, is a is a health service, you know, with a million plus employees covering a population of between 50 and 60 million people. I would say in my travels like that is very, very large in terms of the scale and the span of control. And when people say like, what's the best performing health system in the world? People point out places that are small. It's a very, very large system here in the UK, and that does create that huge amount of variability in subculture as you mentioned.
Sir Jim Mackey (Guest)
It’s completely comprehensive. So there are no exclusions here. Everybody gets it if they need it. There isn't a system as widespread as that. But with that there's a price, there’s a burden, there's a duty. But the connection to society is huge as well, which is I think one of the things we've got to really leverage, and I'll say this all the time when I'm in the North East, there are large parts of the North East, where if you don't work for the health service, you don't work. And we're touching everybody's lives. And everybody has ten people within their radius of contacts. It will have an impact on most of society every day. We’ve got to harness that.
Hannah Gowen (Host)
And so we've kind of set the context for this conversation with some of the challenges, right? But let's move forward and talk about what becomes possible. You touched on community and the innovation that's happening every day. So if we start to look at a problem differently, that can obviously lead to the ability for us to find new solutions. So Sara, I'll start with you in the healthcare sector. Can you give us some examples, something tangible of new solutions available and how they might be used?
Sara Siegel (Guest)
There are so many things now which allow us just to sort of skip the parts of the process that nobody wants to do. The sitting around in the waiting room, the waiting for a physical letter to come back. Jim and I were speaking about a technology earlier today that's being trialled in the NHS, which basically looks at a couple of different pathways of care, and because it connects up different digital systems and allows for asynchronous communication between clinician and patient, allows the patient to not travel into the hospital, allows the clinician to review notes and make judgements, in their free time allows patients to check in directly for diagnostic services if they meet certain criteria.
And even a short pilot of a technology like this reveals like a 94% reduction in outpatient appointments. Like, you can just see that the old way of doing things just required people to travel, to come in, to have a conversation, which now with all the things we have, we just don't have to do anymore. I mean, I always say this, but I really think that we are on the cusp of the most exciting, I don't know, two to five years in healthcare because we do have all of these new tools at our disposal. And the other thing is that they're not all incredibly expensive.
Like, we've spent so much money implementing these big electronic medical records here in the NHS and around the world, and there's a lot of frustration that they haven't maybe delivered the ROI, the return on investment that systems, especially finance directors, wanted. But now we have technologies which are nimbler, which are cheaper, which can sit on top of existing systems and which do deliver very quick results not only to finance directors but to patients and patients can have a better experience.
Hannah Gowen (Host)
And Jim, prevention, we've touched on obviously a big focus for the NHS. What are the wider benefits that a new approach such as flipping to prevention can create, perhaps that you didn't think about in the beginning?
Sir Jim Mackey (Guest)
The real benefit most clinical practitioners love it, first of all. So it brings a bit of joy to life rather than fixing a problem that was avoidable. When you can blend the two you can see people start to get a bit more hope for the future, that they're not fixing a failure effectively. They're actually constructively preventing the failure in the first place. So there’s a bit of joy at work element. I think the other thing is, a lot of these things have a more immediate impact than we think.
So when you look at when we had the smoking bans and you've seen impact on alcohol consumption, we are kind of conditioned to think that these things all have an impact in 20 years. A lot of them don't. They actually have really quite immediate impacts. And if we're thinking especially around the impact on mental health, mental wellbeing for young people especially, I think these things can have a really quite short, quick return if we can just get organised enough to actually do the things that are evidence based and available for access, people can access appropriately.
Which helps with the business case, because one of the big problems we’ve got is if you've got to put money into something to pump prime something now, and I would always be suspicious of this, somebody will say, I'll give you a business plan and it will provide a return in five years time and maybe think, well we might all be out of business in five years time. We haven't got that. You know, I want to see that in three months. I want to see it in six months. Maybe within a year. That's fine. We're all having to compress how we look at these things.
So I think there's a kind of mind shift required and prevention that has become a bit self-defeating, that we can do it. We can only do it at the expense of something rather than alongside it. But also we'll do it, and then the benefit is so far into the future, it makes everybody think, what's the point? It's much, much nearer than that.
Sara Siegel (Guest)
That's such a good point. Like there are real big reasons to be proud about prevention. Smoking bans had a massive impact. I think another point of pride would be genomics. So, for example, every baby born has a heel prick test where a drop of blood is taken from their heel when they're born. We now have the capability to do a full genomic sequencing using that blood, which means that for the generation of babies born now, we can put a whole prevention plan in place for any diseases that they might be predisposed for, which is a whole new way of thinking about prevention at a very low cost.
And I think we forget that the UK was a huge pioneer in genomics, and we still, I'd say we still lead the way there.
Gerry Popova (Host)
Let's look now at what might actually get in the way. What can really prevent organisations, once they have found that right solution to actually implement it and make it a success?
Sara Siegel (Guest)
So it all comes down to people. We were talking about this earlier today. People are the thing that makes programmes succeed and fail. And in health services like the NHS, clinicians are the most important cohort to either drive success or to prevent the success of any programme. When I speak to colleagues who work in other industries in financial services or consumer products, they always look at health services and they think like, “why doesn't it work like the banking app on my phone or the Tesco app?” Or, you know, the rest of their life or how they consume media, for example.
And I think the big difference between health and the rest of society is that, A, it's very complicated. As Jim has already alluded to, there's not a cookie cutter process like there is for a tin of beans getting to a shelf at Tesco. Human bodies and systems are incredibly complex and not that formulaic. So, you know, medicine is part science, part art. And that's why the clinical part of change is so important. So I mean, I know that when we take on big change programmes, we always make sure that the clinicians who work at Deloitte are a big part of it.
And the clinicians who are leading the programmes are a big part of it, and that they are the ones leading the programme. Because without clinical buy-in and the understanding from the clinical community, there will be no change.
Gerry Popova (Host)
But we also have to touch on technology, right? And we can't have a conversation about technology without AI. We also know that the general public are using it on an individual basis. And according to a recent Deloitte survey, a quarter of GenAI users are turning to it for health advice. Jim, does this highlight a challenge or an opportunity for healthcare?
Sir Jim Mackey (Guest)
It's both again, I think. I remember a few years ago, people have been a bit worried about ”Doctor Google“ and turning up with a self-diagnosis in clinic or, you know, with a GP, etc. so there's a it's moved on a bit. It's obviously, you know, it's... the power is much greater through AI etc., but it's a sort of version of that. We have to harness... we're living with AI now in healthcare. It's everywhere. It's being tried, adopted, as Sara's described. It's in use. It's in use in society. We're going to have to lean into it.
I don't think there's a King Canute approach where we say this is all really dangerous and scary, so we'll just shut our eyes and ears and pretend that healthcare is immune from it. We have to find a way of embracing it, making it useful, and making sure risk's manage appropriately. Everybody kind of understands it. It's got its right place in the system. And I think on the societal point, we've got to beat that in terms of access. We've got to beat the offer.
We've got to make the public feel like accessing our public health system, the NHS, is a better, more reliable thing than looking at your phone and looking at ChatGPT or whatever else and making it up for yourself what you've got. So in part, people doing that is a we've established a path that may be partly, at least in part, resolved through reduced access. We've got to improve access so and embrace the technologies and use the technologies to improve the outcome for people.
Sara Siegel (Guest)
So AI is kind of a frenemy to the NHS.
Hannah Gowen (Host)
I think. I mean, we've sort of alluded to there the risk that “Doctor Google” or technology being used as a as a crutch for health advice. Sara, can I ask you, how do you think organisations can balance the innovation of something like AI and the risk appetite going too far into it and being worried about what the consequence will be?
Sara Siegel (Guest)
I mean, I think that governance around AI is just the most massive topic, and it's something that I don't think any organisation has fully come to grips with yet. That same worker survey that we did of 25,000 workers in the UK, showed how prolific use of AI was for work purposes outside of sanctioned work tools in all sectors of the economy, in the UK. That was private sector, public sector and we did a cut for the NHS too, So I think the governance of it is just an absolutely huge issue.
And we saw that with clinicians as well when tools first, because clinicians are so innovative, when tools first become available, they want to play with things. They want to build a little add-on to help, you know, do an ECG read faster or whatever. So that is just going to be absolutely huge. But I kind of want to go back to Gerry's question that Jim spoke to a little bit too, because I think that the rise of AI presents a lot of different opportunities and challenges.
And one of the things that I'm watching with great fascination, which Jim has just alluded to, is the potential rise, or I would say the near-certain rise of health consumerism. So if I take a step back, when I moved here from the U.S. 25 years ago, I sort of thought, you know, there will be a strong voice for patients in the NHS. And I was 100% wrong. You know, patients do what their doctors are told. Their biggest issues are wait time and car parking. They will not shop around for a doctor. It's a very different health system to the one that I grew up in that is actually changing now.
And because of the likes of “Doctor Google” and ChatGPT. Stats show that up to one third of all AI searches are health related. If you look at the Anthropic S-1, a lot of the causes that they put in for why this is a good technology, are healthcare related front-end R&D for life sciences, etc.. So I feel like just as Jim said, we are kind of in a way in a race with AI, but in a good competitive race. And I love thinking about the future of industry, and I wonder whether there will be different models of care in the future.
One, potentially a very data heavy model which comes from outside of our health services, which consumers can access, which is almost a parallel track to traditional healthcare and where you don't need physical intervention. Maybe there's no touch at all between a service like the NHS and a citizens experience of healthcare, and I think that's a very interesting future to imagine, and one that was coming at us very quickly, and one where regulation and governance are going to be incredibly, incredibly important. Because right now, remember, people are searching up health conditions using these AI tools. And as far as I know, none of them are actually properly regulated by the health regulators
Hannah Gowen (Host)
in any country. And Jim, I’ll come to you, how do you think that organisations such as NHS England can balance the opportunity of innovation with that risk appetite?
Sir Jim Mackey (Guest)
We're looking at lots of things currently around the regulatory system, the oversight system, board capability, financial flows, incentivisation, all of those things are in play where we're trying to support the whole balance of delivering day-to-day, do what's important today, but try and develop these capabilities and give us confidence over time that we’re getting the balance right. And we're not just finding innovations, we're able to adopt them and spread them more quickly. Because I think one of our big problems actually in our system is not that the innovation exists, it's that it exists and it's not being spread or it's not being spread quickly enough.
So at a national level, I think there's a problem here in our current psychology where we'll look too much to national for solutions. In reality, most of the solutions are local, are in the institution and the system that you're working in day-to-day. That's really where all these things actually get brought to life. So there's a sort of first point nationally, do no harm, so try and not prevent it, not do things that harm it, you know, create perverse incentives, etc.
And over time, build the mechanisms and the financial flows and the regulatory proportionality that's Sara alluded to earlier on to encourage people to take good proportionate risk, create the capacity capability, but keep the balance as healthy as they can do.
Gerry Popova (Host)
And Jim, you spoke about how important people are as part of that equation towards success. I wonder what are your thoughts around balancing the power of AI and that human judgement?
Sir Jim Mackey (Guest)
So this is a really big part of how we're going to have to embrace this properly. It's often portrayed that AI just replaces humans completely. There's always and this is a really big concern that clinical colleagues have, it should allow us to free up the time and space and improve the place for judgement to be applied by removing a lot of the other noise and decision making and filtering, you know, etc.. So that's happening in various clinical processes and administrative processes around the NHS. But I think just continuing to reinforce the not mutually exclusive, the we need all of those things to work together.
And as we get more used to using the technologies, it will become clearer where the technology has to be augmented by a human judgement or a human process to to sit on top of it.
Hannah Gowen (Host)
How do you tackle the challenge of the skills gap and training your people when there is so many of them and so many new skills to learn at all times?
Sir Jim Mackey (Guest)
Yeah, so the the education system, because in healthcare, the clinical workforce generally goes through very long educational processes. So those processes need to be keeping up to date and making sure that people who are starting off now in nursing education or a physio or a medical education, some description, this is actually being built in and incorporated. I'll come back to that because there's a point about some of our other service changes. So catching people as they're coming through and being as adaptive and making sure people have the skills to be able to do this when they're actually practising, and then for the existing workforce, who's already there.
A lot of people are self-educating on this, and we have to accept and understand that. So there's a risk of that. But institutions are increasingly laying on their own courses, their own education targeted this specific training and education around specific projects and implementation, etc. But I think there's a bit of a job about raising general awareness, general... getting comfort levels up with it, our ability to just feel able to work with these things as well. And that's hard in an institution such as the one we're working in today, 17,000 people here, all very busy.
They’ve all... it is quite hard getting there all the normal training done as well as these additional things, but it is one of our challenges. Just on that point, going back to the catching people in the clinical education process being as adaptive as possible. I do worry about this. We're currently training today medics on the outpatient point to perform an outpatient consultation, in much the same way as they would have done a few hundred years ago. By the time they are practising and are experienced as consultants, for example, or, you know, experienced GPs, the world will have completely changed around them.
So we are going to have to find an education approach that teaches the basics, all of the things that are necessary but can tune into the rest of society because the pace at which this is moving now could mean that we're producing people who then live in a clinical environment when the time is right and they don't understand it. It's not what they're used to.
Sara Siegel (Guest)
I totally agree. I mean, I think that education writ large needs a big overhaul. Just considering the pace of change that we're experiencing in society, not just, you know, for medics, but sticking to the NHS. I think that the whole period of one's career where you have little snippets now of kind of continuing professional development needs to be a much bigger proportion of one's time just because of all of the new surgical techniques, like you name it, that are coming through. It's not fair to a 50 or 60 year old consultant who trained, you know, 40 years ago to be up on those things if we're not constantly helping them to reskill.
So I think it's just about putting a different weight in the balance of training. And training is a lifelong thing now, and it needs to be built into work plans and all of that. That's a, that's a big change.
Hannah Gowen (Host)
So we've spoken about what social impact healthcare has on communities. So let's take a moment to consider what other organisations are doing to help communities.
-- The podcast transitions into an episode break for a Social Impact message from our host, with background music --
Gerry Popova (Host)
Right now, too many people across the UK are facing hunger and financial hardship. That's why we're proud to support Trussell through our Social Impact programme, an anti-poverty charity and community of food banks. Trussell works together to ensure no one in the UK needs a food bank to survive, while providing emergency food and practical support for people left without enough money to live on. You can play your part too. Search “Trussell” to find out how you can help.
-- The podcast transitions back to the main episode as the music ends --
Hannah Gowen (Host)
So innovation and technology can open up what's possible and provide new solutions to old problems. But to create real progress, organisations have to be able to properly implement this new approach. So Jim, how can organisations find the capacity to prioritise making change for a better future versus meeting present demands? It comes back to that same "today versus tomorrow" debate.
Sir Jim Mackey (Guest)
Yeah So people are across the service to different, different degrees. We've obviously got parts of the NHS that have really deep, stubborn problems and we have to help them implement new things, new technology, you know, approach etc. But the effort, first of all, is trying to come back to one of my earlier answers, provide a system that encourages local boards, local teams, local institutions to get the balance right. Use techniques that work, use evidence and data, have an improvement approach. Have a board capacity and capability, have an oversight system and a governance system. You know, so there's a bunch of raw ingredients in all of this that healthy organisations need to have.
And it is the role of the leaders in the organisation to keep the balance right. And we're just about to go into winter, for example. So if I was in my Trust job now, I'd be thinking, if we're on the edge of trying something interesting and clever and innovative, there's a reality of life that means in a few weeks time, everybody will just be managing winter. So don't do things at times when you've got no chance of actually being able to do them. There's never really a quiet time, but you can avoid really obviously very difficult times to do it. Apart from even if you could pull it off, it jars with people.
It creates a distortion and prioritisation and confidence on decision making, etc. So stay in sync with the normal kind of demands and flows and cycles that you're working with. But it is the job of the local board, of the chief exec, of the leader, to be able to create the capacity and capability, however hard it is. Manage yourself in all of that to try and get the balance right. One of the things that's occurred to me a few times through the discussion is deliberately making sure you've got people in the team who are maybe a bit out there, maybe going to have a different view.
Maybe you might not put them on a delivery project necessarily, because their contribution is more disruptive, it's more sparky you know, etc. So there's a sort of composition of the team at every level that you need to get the balance right, because if everybody's of the same view and of the same thought process, you're locked in. It's built for what it's doing, then that's all you're going to get.
Hannah Gowen (Host)
We've touched on our recent GenAI Workforce Survey already, Sara, and we have pulled on a couple of points. I think the really interesting one here is that 20% of people reported that their leaders spoke about using AI and had a good understanding of it, and that's just in the healthcare setting. So what do you think needs to happen to help leaders drive that adoption and embed the new ways of working? Because, like you say, in a massive organisation, there's lots of layers and that innovation and implementation can be quite hard work, can't it?
Sara Siegel (Guest)
It can be quite hard and 20% sounds quite low. But I think we have to remind ourselves that this is a technology which has landed on all of us at the exact same time. We don't have leaders who are trained in GenAI as they were being educated. You know, we're all learning about at the same rate, at the same pace, and it's changing absolutely massively. So I think this is an opportunity for us to, A, get together and learn collectively, B, be less hierarchical. Sometimes it's, you know, the 20-somethings and the 30-somethings who are really understanding these technologies and how they can be used in a really quick and adaptive way.
Better than the 40-somethings or the 50-somethings not to put an age on it. So I think it's an opportunity for us to learn in a different way. And maybe it's not the chief exec or the board chair that we need to look to for the GenAI insight, right. Those people can't be in charge of all of the areas of expertise. One of the things I say to our global healthcare leaders around the world is, let's all do this together. Like, I don't want to see one team building a digital twin for an A&E or an ED, as they call it in the US.
Let's think about this collectively, because we're all solving the same problems with AI at the same time.
Hannah Gowen (Host)
And is there anything that the healthcare sector can learn from other industries in this case?
Sara Siegel (Guest)
I think we are going fast. I would say there are other sectors of the economy, like within financial services. Insurance has been pretty aggressive at implementing GenAI into some of their middle office processes. I think a lot about maybe the front door in the back office of health service processes, especially when there's not a huge clinical component where we could probably learn from some of the lessons of the insurance sector and put some of those pathways and processes in place, like an example that comes to mind is post-discharge from an acute episode or an elective surgery. There's not always the routine follow up call that could or should happen to a patient in their home.
Other countries, like Canada, we’re piloting an AI avatar video call to patients, and that's filling a void, those calls weren't happening before. And that's good because we're collecting clinical data. We're having a touch point with the patient. Oftentimes we're routing them into other services that they had questions about, or appointments that they had missed or needed to schedule. We're also getting increased feelings of well-being from those patients, because they can speak to the AI avatar for two minutes or two hours, right? It's not a human that needs to get through a call sheet.
So there's a lot of things like that that I think we can bring to the health service that will feel really different to patients and improve quality.
Sir Jim Mackey (Guest)
I’ll just add to that there was an inference in your question. I don't know whether it was deliberate or not, but it came across as how do we, as healthcare institutions make our staff adopt AI? They are using it. And there's, if you reverse that, a few months ago we had an intern in the in NHS England, in our office, arrived, and the work they were dealing with, they were very experienced with AI and within a couple of days this intern was basically, “I'm not doing that in the way you've described it. I'll use AI, I’ve changed the process.
This is how it looks.” So there's something I thought it's just fantastically powerful that sometimes what we can do is just get out of the way and just allow people and enable people. We obviously need safeguards, we need safety nets, etc. because we're in a high-risk environment. But I don't think it's the case that we're having to find ways of enforcing the adoption of something because our work life, our health life is part of our other life and everybody's using it. We just have to find its place. But in all, in all of this, we're talking a lot about technology. Healthcare is still and always will be human. Yeah.
So again, don't let the technology squeeze out the human interaction, the eye contact, the acknowledgement, the saying hello, the finding the patient who looks lost. You know, all those things matter. And we might be using all leading-edge technology, but the things that make people feel safe and have a sense of belonging and compassion, etc.
Sara Siegel (Guest)
That's such an important point we need to get our faces out of our phones. Yeah, look at each other. Another great example of storytelling. To just elaborate on Jim's point at Deloitte, we publish an impact report every year, and this year in the impact report, we put the story of one of our programmes with the NHS, the One Devon programme, where we put simple self-service mechanism over the top of HR tools so that people could query policies and just do a lot more things for themselves across Devon. And that freed up a lot of capacity and just created a lot of access for tens of thousands of employees across the NHS in Devon.
And it was in our impact report, I just put it on my LinkedIn, and you wouldn't believe the number of queries I've gotten about it from around the country and also all over the world. How did this work? What did staff think? What technology do you use? How long did it take? What was hard? I mean, people are really interested to learn about things that work.
Gerry Popova (Host)
Now, I'd like to move us on to some key takeaways based off of our discussion from today. Jim, how can a leader decide whether they should persist with an approach or rethink it entirely?
Sir Jim Mackey (Guest)
You have to have mechanisms to do this. Personal mechanisms and your own practice and approach in the team, in the governance system. So if you're trying a new approach, part of our bureaucracy will mean there's probably a business case of some description, sometimes enormous, sometimes quite brief. Describe what you're trying to do. How are you going to measure success? How are you going to keep a track of it? And a part of that is if it's not working or if it's working in a different way, you have to have the strength, the governance, the wherewithal and the humility to be able to say, well, actually, that's not doing what it was supposed to do.
We'll take a few steps back or we'll stop it and we'll try something else. If I was able to, I would show you I've got a thing called my favourite slide. It's in our documents called My Favourite Slide, which is an improvement slide from the orthopaedic team in Northumbria, who over 20 years tackled surgical site infection. And the point of the slide is, they set off with a purpose. That's measurement they had an improvement approach as to how they were going to go about it. And over time things worked and didn't work.
But the point that it shows where they regrouped, they saw in the measurement, whether something was working, whether patients were happy with it, whether they was getting the right kind of results. And then they changed approach. Tried something else, and accepted the most powerful thing in it, as I think, was they were accepting that they were never going to reach a destination. It was a process that was going to be with them forever. And psychologically, that's how they embrace it. It's a really fantastic thing. I've been using this thing for 20 odd years, so I've still not found anything that describes improvement as well as that single slide.
Sara Siegel (Guest)
I really want to see that slide.
Gerry Popova (Host)
And speaking about progress and that time and investment that people need to make. Sara, what is the most important step from your professional experience around a business trying to make a real change and an impact?
Sara Siegel (Guest)
This is going to sound like sort of a strange answer, but I think psychological safety is really important. And I think the ability to speak up and put out a view which might be contrary, even if you're really junior saying it to a really senior person is a great thing and it does not exist in many, many, many organisations.
I don't think that's normal, but I think that that sort of thing, while it can be disruptive, is a way to really put a little bit of grit into the system and really challenge traditional thinking and make sure that we're getting to good answers, because I think oftentimes, you know, there's a lot of politics, perception is important. And when investments been made in a project or a programme, there's pressure to show that it's succeeding.
I almost think putting up a target that says like one third or pick your number of all projects are expected to fail, but let's call it, and can that project and reallocate the funding and take our learnings and put something better into the pipeline. And I think that's not part of traditional culture, and that's something that we should definitely seek to redress.
Hannah Gowen (Host)
And finally, it's been a very, very interesting conversation. Thank you both. Let's bring it back to today's big question, which is: How do we rethink the way we solve problems? Jim, I'll start with you.
Sir Jim Mackey (Guest)
It's complicated. You have to have processes, team composition, leadership skills, engagement, measurement, curiosity, the desire to find things that might be better, might be solutions, and then be able to engage people in a way that makes it feel safe, empowering, hope rests in it, etc. in a way that allows people to actually lean in and understand that our jobs and our lives require us to do both things, delivering day-to-day and finding a new way forward. And in all of that, as we've said a few times, let's not buy this isn't happening. It's happening.
It's probably not happening at the right pace, and it's probably not being shared in the way that the pace would like it to be. But the NHS actually is reinventing itself every day in every single institution.
Sara Siegel (Guest)
So something I do sometimes is when I'm stuck on a really big, complicated programme or things aren't going well, I'll try to articulate the problem to my 11-year-old and just put it in words that he can understand, and then I'll just see what he says. And that's really helpful, because then that gets me to kind of like the base answer. So objectively, if there weren't a million complications here would be the answer to the problem. And that gives me a North Star. And then obviously I have to lay on all the people issues and everything else that comes on top of it. But sometimes that's something that really helps to reground me.
Hannah Gowen (Host)
Thank you. That's super interesting. Thanks for joining us today.
Guests (together)
Thank you so much.
-- Outro music of The Green Room begins followed by our host talking --
Hannah Gowen (Host)
Thanks for listening to this episode of The Green Room, a Deloitte podcast. We release a new episode every other Tuesday with another big question. So don't forget to hit, follow or subscribe to this podcast wherever you're listening or watching and make sure your notifications are on. So that way you'll be alerted whenever a new episode drops. This podcast is produced by our very own Pod Squad. Original music by Ali Barrett.
-- The podcast music fades up and the episode ends --